May 25, 2006

 

UK biotechnologists achieve breakthrough against bird flu
 

Press release
 

 

A team of biotechnologists in the UK has achieved a significant breakthrough against the H5N1 bird flu virus.

 

A non-toxic, organic, bioflavanoid-based compound, Citrox MDC, has been tested at Professor John Oxford's independent Retroscreen Virology Ltd. (London), and proven to be 99.9998 percent effective against the H5N1 virus. It is commercially available under the trade name "Nvirox".

 

Nvirox is available in sufficient quantities to combat an outbreak of H5N1, preventing the avian flu virus from spreading and thus minimising the risk of the virus entering the human population.

 

The aerial decontaminant Nvirox is applied by the method of 'fogging' in all types of poultry houses. It is easy to use, with no special precautions needed in its application as a 2.0 percent solution in water as a 'fog' to the environment in which poultry live, and to footwear, clothing, vehicles and other possible transmitters of the virus.

 

Unlike other compounds in general use, Nvirox is safe. It is non-toxic and environmentally friendly, posing no danger to either humans or livestock. It is also non-carcinogenic, non-allergic, non-mutagenic and non-corrosive.

 

As a blend of natural compounds based on organic ingredients (compliant with EU 2092/91), Nvirox affords farmers the opportunity to combat avian flu without compromising their status.

 

Applying Nvirox is also more cost efficient than administering anti-viral drugs, instituting a vaccination programme, or mass culling.

 

For technical and scientific information, contact:

 

EPAC, Hoogerheide, The Netherlands

Tel: +31-164-660158 

E-mail: epacho@planet.nl